Hollingshead James 4
4 · RESMED INC · Filed Nov 18, 2021
Insider Transaction Report
Form 4
RESMED INCRMD
Hollingshead James
President, Americas
Transactions
- Award
ResMed Common Stock
2021-11-18+1,393→ 78,805 total - Award
ResMed Common Stock
2021-11-16$254.81/sh+20,360$5,187,932→ 89,472 total - Tax Payment
ResMed Common Stock
2021-11-17$254.81/sh−12,060$3,073,009→ 77,412 total - Award
ResMed Common Stock
2021-11-18+316→ 79,121 total
Footnotes (4)
- [F1]Represents performance-based restricted stock units granted on November 14, 2018. The shares were earned on November 16, 2021, when the compensation committee certified that the performance metrics were met.
- [F2]Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/14/2018.
- [F3]Represents performance-based restricted stock units granted on November 19, 2020. The shares were earned on November 18, 2021, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date.
- [F4]Represents performance-based restricted stock units granted on July 1, 2020. The shares were earned on November 18, 2021, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date.